303 related articles for article (PubMed ID: 16019757)
1. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens.
Amin M; Boccon-Gibod L; Egevad L; Epstein JI; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
Scand J Urol Nephrol Suppl; 2005 May; (216):20-33. PubMed ID: 16019757
[TBL] [Abstract][Full Text] [Related]
2. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
Epstein JI; Allsbrook WC; Amin MB; Egevad LL
Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer.
Bostwick DG; Foster CS
Semin Urol Oncol; 1999 Nov; 17(4):222-72. PubMed ID: 10632123
[TBL] [Abstract][Full Text] [Related]
4. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
Epstein JI; Amin M; Boccon-Gibod L; Egevad L; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
Scand J Urol Nephrol Suppl; 2005 May; (216):34-63. PubMed ID: 16019758
[TBL] [Abstract][Full Text] [Related]
6. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
Epstein JI; Herawi M
J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
[TBL] [Abstract][Full Text] [Related]
7. The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers.
Zhou M; Epstein JI
Pathology; 2003 Dec; 35(6):472-9. PubMed ID: 14660096
[TBL] [Abstract][Full Text] [Related]
8. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Prostate Cancer Working Group.
Grignon DJ; Hammond EH
Arch Pathol Lab Med; 1995 Dec; 119(12):1122-6. PubMed ID: 7503660
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the reporting of prostate carcinoma.
Epstein JI; Srigley J; Grignon D; Humphrey P;
Hum Pathol; 2007 Sep; 38(9):1305-9. PubMed ID: 17707261
[TBL] [Abstract][Full Text] [Related]
10. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the cancer committee, college of american pathologists. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer.
Henson DE; Hutter RV; Farrow G
Arch Pathol Lab Med; 1994 Aug; 118(8):779-83. PubMed ID: 8060223
[No Abstract] [Full Text] [Related]
11. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
[TBL] [Abstract][Full Text] [Related]
12. Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices.
Abati A; Simsir A
Clin Lab Med; 2005 Dec; 25(4):631-54, v. PubMed ID: 16308084
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for the reporting of pleural mesothelioma.
Butnor KJ; Sporn TA; Ordonez NG;
Hum Pathol; 2007 Nov; 38(11):1587-9. PubMed ID: 17276491
[TBL] [Abstract][Full Text] [Related]
14. A clinical dilemma; single prostatic cancer focus in biopsy. Interpretation and management.
Efthimiou I; Skrepetis K; Bournia E
J BUON; 2010; 15(1):19-24. PubMed ID: 20414922
[TBL] [Abstract][Full Text] [Related]
15. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond ME
Arch Pathol Lab Med; 2014 Oct; 138(10):1387-405. PubMed ID: 25092589
[TBL] [Abstract][Full Text] [Related]
16. Prognostic markers in prostate cancer.
Ross JS; Sheehan CE; Fisher HA; Kauffman RA; Dolen EM; Kallakury BV
Expert Rev Mol Diagn; 2002 Mar; 2(2):129-42. PubMed ID: 11962333
[TBL] [Abstract][Full Text] [Related]
17. 2005 update on pathology of prostate biopsies with cancer.
Montironi R; Vela-Navarrete R; Lopez-Beltran A; Mazzucchelli R; Bono A
Eur Urol; 2006 Mar; 49(3):441-7. PubMed ID: 16413665
[TBL] [Abstract][Full Text] [Related]
18. [Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)'].
Maeda O; Usami M
Nihon Rinsho; 2005 Feb; 63(2):201-6. PubMed ID: 15714966
[TBL] [Abstract][Full Text] [Related]
19. What's new in prostate cancer disease assessment in 2006?
Epstein JI
Curr Opin Urol; 2006 May; 16(3):146-51. PubMed ID: 16679850
[TBL] [Abstract][Full Text] [Related]
20. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications.
Henry PC; Evans AJ
J Clin Pathol; 2009 Jul; 62(7):579-83. PubMed ID: 19246509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
